Company intelligence
Oppenheimer & Co. Inc.
Oppenheimer provides a full range of wealth management, securities brokerage, and investment banking services.
About Oppenheimer & Co. Inc.
Oppenheimer is a global financial institution offering Wealth Management, Capital Markets, and Investment Banking solutions. We have been providing customized strategies centered on the goals of our clients since 1881 — using our extensive experience, resources, research, and knowledge to help advance society, improve our communities, and leave the world a better place.
Verified activity
Signals from Oppenheimer & Co. Inc.
17 published signals
Customers & Market
Oppenheimer & Co. Inc. acted as an exclusive financial advisor to 1251 Capital Group, Inc. on the sale of Red Granite to F.L.Putnam Investment Management Company
Reported by Oppenheimer & Co. Inc.
Presence & Recognition
Oppenheimer & Co. Inc. announced that Elizabeth Coolidge's Head of Public Finance will serve as a co-chair of The Bond Buyer's 2026 Infrastructure Conference in Chicago, September 14–15, 2026.
Reported by Oppenheimer & Co. Inc.
Presence & Recognition
Oppenheimer & Co. Inc. tech analyst Timothy Horan joins the Power Lunch to discuss SpaceX, the company's recent acquisition, and much more.
Reported by Daniel Krall
Presence & Recognition
Oppenheimer & Co. Inc. celebrated Happy Labor Day with a lab day event hosted by The Lynch Group.
Reported by Darryl J. Lynch
Presence & Recognition
Oppenheimer & Co. Inc. tech analyst Timothy Horan joins the Power Lunch to discuss Oppenheimer's view on SpaceX, the company's recent acquisition, and much more.
Reported by Thomas (Tom) Avazian
People
Oppenheimer & Co. Inc. promoted Lauren Carter to Head of Negotiated Underwriting.
Reported by Oppenheimer & Co. Inc.
People
Oppenheimer & Co. Inc. added Bruce Rideaux as Managing Director in Texas.
Reported by Oppenheimer & Co. Inc.
Presence & Recognition
Oppenheimer & Co. Inc. employee Michael Margolis, R.Ph., Head of Healthcare Life Sciences Investment Banking, will speak at the 2nd Annual Global Cancer Research and Innovation Symposium (GCRIS) panel titled Pharma Bets and the Emerging M&A Landscape.
Reported by Oppenheimer & Co. Inc.
Presence & Recognition
Oppenheimer & Co. Inc. tech analyst Timothy Horan joins the Power Lunch to discuss SpaceX, the company's recent acquisition, and much more.
Reported by David Vanech
Capital & Finance
Oppenheimer & Co. Inc. served as active bookrunner on Backblaze's upsized $201M convertible senior notes offering.
Reported by Nitin Doke
Capital & Finance
Oppenheimer & Co. Inc. served as a joint lead placement agent on the ~$33M PIPE for Corvex, Inc.
Reported by Nitin Doke
Customers & Market
Oppenheimer & Co. Inc. acted as an exclusive financial advisor to F/m Investments LLC on its sale to T. Rowe Price.
Reported by Oppenheimer & Co. Inc.
Presence & Recognition
Oppenheimer & Co. Inc. earned PSN Top Guns recognition for Q2 2026 for its Corporate Core Plus Strategy, receiving distinctions in the Core Plus and Long Maturity universes.
Reported by Oppenheimer & Co. Inc.
Research & Knowledge
Oppenheimer & Co. Inc. released the latest edition of Research Bites, featuring concise, data-driven insights designed to help investors navigate evolving market conditions.
Reported by Dave Carey, CIMA®
Presence & Recognition
Oppenheimer & Co. Inc. hosted the Morning Show with JC Parets featuring Ari Wald, CFA, and CMT.
Reported by Daniel Krall
People
Oppenheimer & Co. Inc. welcomed Joel Berry II as a Financial Advisor with the Robinson Private Client Group in Winston-Salem, North Carolina.
Reported by Oppenheimer & Co. Inc.
Research & Knowledge
Oppenheimer & Co. Inc. released the latest edition of Research Bites featuring concise, data-driven insights designed to help investors navigate evolving market conditions.
Reported by Thomas (Tom) Avazian